<?xml version="1.0" encoding="UTF-8"?>
<results title="viral_systemic_diseases">
 <result pre="Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome" exact="Coronavirus" post="Infections Behzadi Mohammad Amin Leyva-Grado Victor H. * [],"/>
 <result pre="and others had recently emerged as a public health problem." exact="Influenza" post="viruses have been affecting the human population for a"/>
 <result pre="antibody, is recommended for prophylactic use in high-risk patients. The" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) is a newly emerging respiratory virus. The"/>
 <result pre="MERS-coronavirus novel therapeutic agents Funding NIAID-funded Center of Excellence for" exact="Influenza" post="Research and Surveillance-CEIRS HHSN272201400008C fig-count: table-count: equation-count: ref-count: page-count:"/>
 <result pre="of seasonal influenza viruses (H3N2var), and the emergence of the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) highlight the serious and important need for"/>
 <result pre="antiviral therapies ( Zumla et al., 2016; International Society for" exact="Influenza" post="and other Respiratory Viral Diseases, 2018). This review article"/>
 <result pre="of (A) influenza virus, (B) respiratory syncytial virus, and (C)" exact="Middle East respiratory syndrome" post="coronavirus, indicating where each therapeutic exerts its antiviral activity."/>
 <result pre="activity. Drugs approved by the FDA are shown in bold." exact="Influenza" post="Virus Influenza virus is a negative sense, segmented RNA"/>
 <result pre="approved by the FDA are shown in bold. Influenza Virus" exact="Influenza" post="virus is a negative sense, segmented RNA virus that"/>
 <result pre="bold. Influenza Virus Influenza virus is a negative sense, segmented" exact="RNA virus" post="that presents a substantial burden to human health. Despite"/>
 <result pre="is an emerging zoonotic disease caused by a virus called" exact="MERS coronavirus" post="(MERS-CoV). This virus is an enveloped, single-stranded, positive sense"/>
 <result pre="coronavirus (MERS-CoV). This virus is an enveloped, single-stranded, positive sense" exact="RNA virus" post="with a large genome (approximately 30 kb in length)"/>
 <result pre="et al., 2013) and digestive symptoms including nausea, vomiting, and" exact="diarrhea" post="( Centers for Disease Control and Prevention, 2017) with"/>
 <result pre="the treatment of influenza virus, respiratory syncytial virus (RSV), and" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). Therapeutic compound Infectious agent Mechanism(s) of action"/>
 <result pre="Infectious agent Mechanism(s) of action Clinical trial phase NCT# CR6261" exact="Influenza" post="Inhibits the binding of the virus to cell membrane"/>
 <result pre="of the virus to cell membrane receptor 2a NCT02371668 CT-P27" exact="Influenza" post="Inhibits the binding of the virus to cell membrane"/>
 <result pre="the virus to cell membrane receptor 2b NCT03511066 NCT02071914 MEDI8852" exact="Influenza" post="Inhibits the binding of the virus to cell membrane"/>
 <result pre="virus to cell membrane receptor 2a NCT03903718 NCT03028909 NCT02603952 MHAA4549A" exact="Influenza" post="Inhibits the binding of the virus to cell membrane"/>
 <result pre="virus to cell membrane receptor 2 NCT01980966 NCT02623322 NCT02293863 Pimodivir" exact="Influenza" post="Prevents viral RNA synthesis 3 NCT03381196 Favipiravir Influenza Inhibits"/>
 <result pre="NCT02293863 Pimodivir Influenza Prevents viral RNA synthesis 3 NCT03381196 Favipiravir" exact="Influenza" post="Inhibits the activity of the RNA-dependent RNA polymerase 3"/>
 <result pre="activity of the RNA-dependent RNA polymerase 3 NCT02026349 NCT02008344 Fludase" exact="Influenza" post="Prevents viral entry into cells of the respiratory epithelium"/>
 <result pre="entry into cells of the respiratory epithelium 2 NCT01037205 Nitazoxanide" exact="Influenza" post="Impairs the trafficking of the viral hemagglutinin 3 NCT03336619"/>
 <result pre="supported in part by the NIAID-funded Center of Excellence for" exact="Influenza" post="Research and Surveillance-CEIRS (Contract HHSN272201400008C). References References Abarca K."/>
 <result pre="Memish Z. A. ( 2017). Update on therapeutic options for" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV). Expert Rev. Anti-Infect. Ther. 15, 269– 275."/>
 <result pre="2014). Ribavirin and interferon therapy in patients infected with the" exact="Middle East respiratory syndrome" post="coronavirus: an observational study . Int. J. Infect. Dis."/>
 <result pre="S. Al Harbi S. et al. ( 2018). Treatment of" exact="Middle East respiratory syndrome" post="with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial):"/>
 <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocol . Springerplus 4: 709."/>
 <result pre="2013). Epidemiological, demographic, and clinical characteristics of 47 cases of" exact="Middle East respiratory syndrome" post="coronavirus disease from Saudi Arabia: a descriptive study ."/>
 <result pre="25547360 collab: Centers for Disease Control and Prevention ( 2017)." exact="Middle East respiratory syndrome" post="(MERS). Available at: https://www.cdc.gov/coronavirus/mers/index.html (Accessed April 17, 2019). collab:"/>
 <result pre="2019). collab: Centers for Disease Control and Prevention ( 2018a)." exact="Influenza" post="antiviral medications: summary for clinicians. Available at: https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm (Accessed"/>
 <result pre="Disease Control and Prevention ( 2018c). Summary of the 107-2018" exact="Influenza" post="season. Available at: https://www.cdc.gov/flu/about/season/flu-season-2017-2018.htm (Accessed April 17, 2019). Challa"/>
 <result pre="G. Jr. Hensley L. E. et al. . ( 2017)." exact="Middle East respiratory syndrome" post="and severe acute respiratory syndrome: current therapeutic options and"/>
 <result pre="1331– 1342. 10.1007/s40262-017-0522-8 , PMID: 28238203 collab: International Society for" exact="Influenza" post="and other Respiratory Viral Diseases ( 2018). Prevention and"/>
 <result pre="Deval J. ( 2018). Nucleosides for the treatment of respiratory" exact="RNA virus" post="infections. Antivir. Chem. Chemother. 26: 2040206618764483. 10.1177/2040206618764483 , PMID:"/>
 <result pre="Clinical and laboratory findings of the first imported case of" exact="Middle East respiratory syndrome" post="coronavirus to the United States . Clin. Infect. Dis."/>
 <result pre="2015). Ribavirin and interferon-alpha2b as primary and preventive treatment for" exact="Middle East respiratory syndrome" post="coronavirus: a preliminary report of two cases . Antivir."/>
 <result pre="in the human respiratory tract and comparison to ribavirin ." exact="Influenza" post="Other Respir. Viruses 11, 525– 530. 10.1111/irv.12503 28990339 Kim"/>
 <result pre="( 2016). Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for" exact="Middle East respiratory syndrome" post=". Antivir. Ther. 21, 455– 459. 10.3851/IMP3002 , PMID:"/>
 <result pre="26492219 Koszalka P. Tilmanis D. Hurt A. C. ( 2017)." exact="Influenza" post="antivirals currently in late-phase clinical trial. Influenza Other Respir."/>
 <result pre="C. ( 2017). Influenza antivirals currently in late-phase clinical trial." exact="Influenza" post="Other Respir. Viruses 11, 240– 246. 10.1111/irv.12446 , PMID:"/>
 <result pre="IXth international symposium on respiratory viral infections. International Society for" exact="Influenza" post="and other Respiratory Virus Diseases (ISIRV). Matsushita H. Sano"/>
 <result pre="Memish Z. A. Zumla A. I. Assiri A. ( 2013)." exact="Middle East respiratory syndrome" post="coronavirus infections in health care workers. N. Engl. J."/>
 <result pre="Fisher D. ( 2016). A review of treatment modalities for" exact="Middle East respiratory syndrome." post="J. Antimicrob. Chemother. 71, 3340– 3350. 10.1093/jac/dkw338 , PMID:"/>
 <result pre=", PMID: 27585965 Modjarrad K. ( 2016). Treatment strategies for" exact="Middle East respiratory syndrome" post="coronavirus. J. Virus Erad. 2, 1– 4. PMID: 26866060"/>
 <result pre="Z. A. Al-Tawfiq J. A. ( 2013). Therapeutic options for" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) – possible lessons from a systematic review"/>
 <result pre="and the role of peptides as potential therapeutic components for" exact="Middle East respiratory syndrome" post="(MERS): a review . J. Infect. Public Health 11,"/>
 <result pre=", PMID: 26511956 Omrani A. S. Shalhoub S. ( 2015)." exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV): what lessons can we learn? J. Hosp."/>
 <result pre="et al. . ( 2018). Zoonotic origin and transmission of" exact="Middle East respiratory syndrome" post="coronavirus in the UAE . Zoonoses Public Health 65,"/>
 <result pre="Jung Y. et al. . ( 2019). Post-exposure prophylaxis for" exact="Middle East respiratory syndrome" post="in healthcare workers. J. Hosp. Infect. 101, 42– 46."/>
 <result pre="E. Hui D. S. Perlman S. Zumla A. ( 2015)." exact="Middle East respiratory syndrome" post="– advancing the public health and research agenda on"/>
 <result pre="PMID: 26072036 Pielak R. M. Chou J. J. ( 2011)." exact="Influenza" post="M2 proton channels. Biochim. Biophys. Acta 1808, 522– 529."/>
 <result pre="3966. 10.1016/j.vaccine.2018.05.057 , PMID: 29801998 Rabaan A. A. ( 2017)." exact="Middle East respiratory syndrome" post="coronavirus: five years later. Expert Rev. Respir. Med. 11,"/>
 <result pre="H. M. ( 2017). A review of candidate therapies for" exact="Middle East respiratory syndrome" post="from a molecular perspective . J. Med. Microbiol. 66,"/>
 <result pre="2015). IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat" exact="Middle East respiratory syndrome" post="coronavirus pneumonia: a retrospective study . J. Antimicrob. Chemother."/>
 <result pre="meeting on respiratory pathogens, September 3th, Singapore. International Society for" exact="Influenza" post="and other Respiratory Virus Diseases (ISIRV). Trevejo J. M."/>
 <result pre="Wernery U. Lau S. K. Woo P. C. ( 2017)." exact="Middle East respiratory syndrome" post="(MERS) coronavirus and dromedaries. Vet. J. 220, 75– 79."/>
 <result pre="or serum as an element in Middle East Respiratory Syndrome" exact="Coronavirus" post="response . Available at: https://www.who.int/bloodproducts/brn/BRN_PositionPaperConvPlasmaMERSCoV_March2014.pdf?ua=1 (Accessed March 11, 2014)."/>
 <result pre="(Accessed March 11, 2014). collab: World Health Organization ( 2017)." exact="Influenza" post="In Focus: Up to 650000 people die of respiratory"/>
 <result pre="with dromedary immune serum in an experimental animal model for" exact="Middle East respiratory syndrome" post="coronavirus infection . J. Virol. 89, 6117– 6120. 10.1128/JVI.00446-15"/>
 <result pre="26868298 Zumla A. Hui D. S. Perlman S. ( 2015)." exact="Middle East respiratory syndrome." post="Lancet 386, 995– 1007. 10.1016/S0140-6736(15)60454-8 , PMID: 26049252"/>
</results>
